Geneva: A major breakthrough in medical science could be within reach as the World Health Organization (WHO) pushes to eliminate cervical cancer as a public health problem. With vaccination, regular screening and timely treatment, cervical cancer could become the first type of cancer to be eliminated through a coordinated global public health effort.
According to WHO estimates, around 604,000 women were diagnosed with cervical cancer worldwide in 2024, while approximately 280,000 died from the disease. Low- and middle-income countries continue to bear the highest burden, largely due to limited access to vaccination, screening and treatment.
WHO's 90-70-90 Strategy
In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer, setting three major targets to be achieved by 2030.
* 90% vaccination: At least 90% of girls should receive the full HPV vaccine schedule by the age of 15.
* 70% screening: At least 70% of women should undergo high-performance cervical screening by the ages of 35 and 45.
* 90% treatment: At least 90% of women diagnosed with cervical precancer or invasive cancer should receive appropriate treatment.
WHO estimates that achieving these targets could prevent around 74 million new cases and 62 million deaths by 2120.
### HPV: The Main Cause of Cervical Cancer
Almost all cervical cancer cases are linked to persistent infection with the Human Papillomavirus (HPV). The virus is commonly transmitted through sexual contact. Although most infections are cleared naturally by the body's immune system, certain high-risk HPV infections can persist and cause abnormal changes in cervical cells, eventually leading to cancer.
HPV types 16 and 18 are responsible for a significant proportion of cervical cancer cases. Vaccination between the ages of 9 and 14, preferably before sexual activity begins, offers important protection against these high-risk strains.
India and the Global Vaccination Drive
According to WHO data, 166 countries have included HPV vaccines in their national immunisation programmes, with 96 adopting a single-dose schedule. Global HPV vaccination coverage among girls reached 33% in 2025, still considerably below the 90% target.
India is also expanding its efforts to protect adolescent girls through HPV vaccination. However, experts stress that vaccination alone is not enough. Regular screening and timely access to treatment are equally important.
AI and Modern Screening Could Help
Pap smear tests and HPV DNA testing can identify infections and abnormal cervical cell changes before they develop into cancer. Self-sampling methods are also making screening more accessible to women who face difficulties visiting healthcare facilities.
Artificial intelligence is emerging as another promising tool. AI-based systems can analyse cervical images and identify suspicious tissue changes, potentially improving early detection, particularly in areas with limited access to specialists.
### Warning Signs Women Should Not Ignore
Common warning signs include:
* Bleeding between menstrual periods.
* Bleeding after sexual intercourse.
* Bleeding after menopause.
* Unusual or foul-smelling vaginal discharge.
* Persistent pelvic or lower back pain.
* Unexplained weight loss and fatigue.
These symptoms do not necessarily indicate cancer, but medical evaluation is important.
Women living with HIV face approximately six times the risk of developing cervical cancer compared with women without HIV, making regular screening particularly important.
Despite advances in vaccination and treatment, financial inequality, limited healthcare infrastructure and lack of awareness remain major barriers.
WHO's goal highlights an important possibility: cervical cancer may become the first cancer eliminated as a public health problem. Achieving it will depend on making vaccination, early diagnosis and affordable treatment accessible to women across the world.
Reader Comments 0